Literature DB >> 10445936

Treatment of hepatitis C infection. Review underplayed important public health issues.

K Agarwal, D D Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10445936      PMCID： PMC1127052          DOI： 10.1136/bmj.319.7207.450a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus Statement. European Association for the Study of the Liver.

Authors: 
Journal:  J Hepatol       Date:  1999-05       Impact factor: 25.083

Review 2.  Hepatitis C and liver transplantation.

Authors:  M Berenguer; T L Wright
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 3.  Recent advances: hepatology.

Authors:  M McCarthy; M L Wilkinson
Journal:  BMJ       Date:  1999-05-08

4.  Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

Authors:  T Bizollon; U Palazzo; C Ducerf; M Chevallier; M Elliott; J Baulieux; M Pouyet; C Trepo
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

5.  A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.

Authors:  E J Gane; S K Lo; S M Riordan; B C Portmann; J Y Lau; N V Naoumov; R Williams
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

6.  Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

Authors:  T Poynard; P Marcellin; S S Lee; C Niederau; G S Minuk; G Ideo; V Bain; J Heathcote; S Zeuzem; C Trepo; J Albrecht
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

7.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

8.  A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation.

Authors:  M S Cattral; M Krajden; I R Wanless; M Rezig; R Cameron; P D Greig; S W Chung; G A Levy
Journal:  Transplantation       Date:  1996-05-27       Impact factor: 4.939
  8 in total
  2 in total

1.  The impact of hepatitis C in general practice.

Authors:  S Singh; R Miller; S Madge; D Patch
Journal:  Br J Gen Pract       Date:  2000-07       Impact factor: 5.386

2.  Refugees, asylum seekers, and general practice: room for improvement?

Authors:  S Hargreaves; A Holmes; J S Friedland
Journal:  Br J Gen Pract       Date:  2000-07       Impact factor: 5.386
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.